Given the spectrum of therapeutic modalities for moderate-to-severe AD, can you provide a “therapeutic ladder” for how treatments, from corticosteroids to immunologically-based therapies should be sequenced in pediatric and adolescent patients?

Given the spectrum of therapeutic modalities for moderate-to-severe AD, can you provide a “therapeutic ladder” for how treatments, from corticosteroids to immunologically-based therapies should be sequenced in pediatric and adolescent patients?

CLICK HERE FOR CME CREDIT Back to Symposium

Given the spectrum of therapeutic modalities for moderate-to-severe AD, can you provide a “therapeutic ladder” for how treatments, from corticosteroids to immunologically-based therapies should be sequenced in pediatric and adolescent patients?

Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Peter Lio, MD

Peter Lio, MD

Clinical Assistant Professor of Dermatology and Pediatrics
Feinberg School of Medicine
Northwestern University
Chicago, Illinois